Dermata Therapeutics
DRMA
DRMA
6 hedge funds and large institutions have $185K invested in Dermata Therapeutics in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
Holders
6
Holders Change
–
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AC
1
Armistice Capital
New York
|
$133K |
| 2 |
VF
2
Virtu Financial
New York
|
$8K |
| 3 |
TRCT
3
Tower Research Capital (TRC)
New York
|
$3.92K |
Top Sellers
| 1 |
1
Acadian Asset Management
Boston,
Massachusetts
|
$32K |
| 2 |
TSS
2
Two Sigma Securities
New York
|
$0 |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $133K | +$133K | +1,453 | New |
|
|
2
Acadian Asset Management
Boston,
Massachusetts
| $32K | -$11.8K | -136 | -27% |
|
|
VF
3
Virtu Financial
New York
| $8K | +$8K | +90 | New |
|
4
Geode Capital Management
Boston,
Massachusetts
| $7.46K | – | – | – |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $3.92K | +$820 | +9 | +26% |
|
6
Wells Fargo
San Francisco,
California
| $429 | – | – | – |
|
|
TSS
7
Two Sigma Securities
New York
| – | -$11.8K | -74 | Closed |
|
|
8
UBS Group
Zurich,
Switzerland
| – | -$139 | -1 | Closed |
|